bioAffinity Technologies, Inc. (NASDAQ:BIAF) Short Interest Down 35.8% in December

bioAffinity Technologies, Inc. (NASDAQ:BIAF) saw a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 114,000 shares, a drop of 35.8% from the December 15th total of 177,500 shares. Based on an average trading volume of 150,600 shares, the days-to-cover ratio is presently 0.8 days. Currently, 1.2% of the shares of the stock are short sold.

bioAffinity Technologies Price Performance

Shares of NASDAQ:BIAF traded down $0.05 on Friday, reaching $0.68. 167,251 shares of the company were exchanged, compared to its average volume of 393,805. The company has a 50-day moving average of $1.04 and a 200-day moving average of $1.59. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.18. The firm has a market cap of $10.52 million, a price-to-earnings ratio of -0.82 and a beta of 2.98. bioAffinity Technologies has a 1-year low of $0.66 and a 1-year high of $3.62.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.